comparemela.com

Lor Randall News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Randall Highlights the Evolving Role of Surgery in TGCT Management

R. Lor Randall, MD, FACS, discusses the early efficacy seen with both vimseltinib monotherapy and pexidartinib plus surgery in patients with previously unresectable or inoperable diffuse tenosynovial giant cell tumors.

Dr Randall on One-stage Synovectomy in D-TGCT

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.